Compressyn Band selected as finalist in Medical Design Excellence Awards for Implant and Tissue-Replacement Products Category

Dallen Medical, Inc. is pleased to announce that the Compressyn™ Band has been selected as a finalist in the Implant and Tissue-Replacement Products Category of the 17^th Annual Medical Design Excellence Awards competition. Finalists were officially announced in the April Issue of MD+DI (Medical Device and Diagnostic Industry) magazine. Winners will be announced at the 2014 MDEA Ceremony held Wednesday, June 11, 2014 in conjunction with the MD&M East event at the Jacob K. Javits Convention Center in New York.

The Compressyn Band implant is a knotless cerclage device that makes use of a spring to supply dynamic compression to aid in bone healing following open heart surgery. The design of the Compressyn Band is intended to utilize virtually the same technique commonly used by cardiothoracic surgeons for closing the sternum following open chest procedures. Its plate-like rigidity can be delivered at a fraction of the cost of plate & screw systems, and the surgeons have the ability to quickly remove the Bands in those rare cases where getting back into the chest is critical.

The MDEA is the medtech industry's premier design competition committed to searching worldwide for the highest caliber finished medical devices, products, systems, or packaging available on the market. The awards program celebrates the achievements of the medical device manufacturers, their suppliers, and the many people behind the scenes—engineers, scientists, designers, and clinicians—who are responsible for the cutting-edge products that are saving lives; improving patient healthcare; and transforming medtech—one innovation at a time.

"Being selected as an MDEA Finalist is a testament to the perseverance, skill, and innovation of the team here at Dallen," stated David H. Mills, CEO of Dallen Medical. "Having been a part of a team that has won a Medical Design Excellence Award once before, I can attest to the fact that recognition from the medtech industry such as this can be instrumental in taking a start-up company such as ours to the next level. We are very proud and honored to be chosen as a Finalist for this great competition."

Entries are judged by an impartial panel of medtech experts. Unlike other design competitions that are merely styling contests, the MDEA jury is comprised of a balance of practicing doctors, nurses, and technicians alongside industrial designers, engineers, manufacturers, and human factors experts. MDEA jurors comprehensively review entries based on the following criteria: the ability of the product development team to overcome all challenges so the product meets its clinical objectives; innovative use of materials, components, and processes; user-related functions improving healthcare delivery and changing traditional medical attitudes or practices; features providing enhanced benefits to the patient and end-user in relation to clinical efficacy; manufacturing cost-effectiveness and profitability; and healthcare system benefits such as improved accessibility, efficacy, or safety, in addition to providing attention to a critical unmet clinical need.

The 2014 MDEA Juror Panel selected 54 exceptional finalists in 11 medical technology product categories. Selected products excel in 5 areas: manufacturing and technological innovation; design and engineering advancements; patient benefits; business benefits; and overall improvement to healthcare industry.

"We are honored to be recognized by the MDEA judges," added Al Memmolo, COO of Dallen Medical. "And look forward to incorporating this recognition into our commercial campaign."